Literature DB >> 21277377

Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.

Kristin M Page1, Lijun Zhang, Adam Mendizabal, Stephen Wease, Shelly Carter, Tracy Gentry, Andrew E Balber, Joanne Kurtzberg.   

Abstract

Graft failure occurs in approximately 20% of patients after unrelated umbilical cord blood transplantation (UCBT). This could be because of inadequate potency of the cord blood unit (CBU). To this end, we investigated the impact of graft characteristics on engraftment and survival of 435 primarily pediatric (median age: 5.3 years) patients receiving a single-unit unrelated UCBT after myeloablative conditioning from 2000 to 2008. Pre-cryopreservation (pre-cryo) graft characteristics were provided by the banks. Post-thaw parameters were measured on dextran/albumin-washed grafts. Post-thaw recovery of the colony-forming unit (CFU), a biological assay reflecting functional viability of the cord blood cells was the lowest percent age (median 21.2%, mean 36.5%) of the pre-cryo value, regardless of the bank of origin. The cumulative incidences of neutrophil and platelet engraftment were 76.9% (95%, confidence interval [CI], 71.3%-82.5%) and 55% (95% CI, 49.3%-60.7%), respectively. Univariate and separate multivariate models using pre-cryo and post-thaw datasets including clinical parameters identified predictors of engraftment and survival. In multivariate modeling, higher CFU dosing was the only pre-cryo graft characteristic predictive of neutrophil (P = .0024) and platelet engraftment (P = .0063). In the post-thaw model, CFU dose best predicted neutrophil and platelet engraftment (both P < .0001). Comparatively, CD34(+) and total nucleated cell (TNC) were only weakly predictive in post-thaw neutrophil and platelet engraftment models, respectively. In conclusion, CFU dose is a strong independent predictor of engraftment after unrelated UCBT and should be used to assess potency when selecting CBUs for transplantation.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277377     DOI: 10.1016/j.bbmt.2011.01.011

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  40 in total

1.  The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME).

Authors:  Kristin M Page; Lijun Zhang; Adam Mendizabal; Stephen Wease; Shelly Carter; Kevin Shoulars; Tracy Gentry; Andrew E Balber; Joanne Kurtzberg
Journal:  Transfusion       Date:  2011-08-02       Impact factor: 3.157

2.  Predictors of Mononuclear Cell Yield in Patients Undergoing Autologous Mononuclear Stem Cell Therapy in Non-haemopoietic Degenerative Disorders.

Authors:  Deepak Pahwa; Ratti Ram Sharma; Neelam Marwaha
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-26       Impact factor: 0.900

3.  Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.

Authors:  Paul J Simmons; Simon N Robinson; Mark F Munsell; Michael W Thomas; Jeannie A Javni; Nathalie Brouard; Patrick A Zweidler-McKay; Elizabeth J Shpall
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

Review 4.  Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective.

Authors:  Ivan N Rich
Journal:  Stem Cells Transl Med       Date:  2015-07-09       Impact factor: 6.940

5.  CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking.

Authors:  Juliet N Barker; Jane Kempenich; Joanne Kurtzberg; Claudio G Brunstein; Colleen Delaney; Filippo Milano; Ioannis Politikos; Elizabeth J Shpall; Andromachi Scaradavou; Jason Dehn
Journal:  Blood Adv       Date:  2019-04-23

6.  The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units.

Authors:  Yoshikazu Matsuoka; Fumiaki Nakamura; Kazuo Hatanaka; Tatsuya Fujioka; Satoshi Otani; Takafumi Kimura; Yoshihiro Fujimura; Hiroaki Asano; Yoshiaki Sonoda
Journal:  Int J Hematol       Date:  2018-07-25       Impact factor: 2.490

7.  Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells.

Authors:  M Kwon; C Martínez-Laperche; P Balsalobre; D Serrano; J Anguita; J Gayoso; J L Díez-Martín; I Buño
Journal:  Bone Marrow Transplant       Date:  2013-11-11       Impact factor: 5.483

Review 8.  Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants.

Authors:  Shalini Shenoy
Journal:  Stem Cells Transl Med       Date:  2013-04-11       Impact factor: 6.940

9.  Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.

Authors:  Kristin M Page; Adam Mendizabal; Brigid Betz-Stablein; Stephen Wease; Kevin Shoulars; Tracy Gentry; Vinod K Prasad; Jessica Sun; Shelly Carter; Andrew E Balber; Joanne Kurtzberg
Journal:  Transfusion       Date:  2013-05-27       Impact factor: 3.157

10.  A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

Authors:  Suhag H Parikh; Adam Mendizabal; Cara L Benjamin; Krishna V Komanduri; Jeyaraj Antony; Aleksandra Petrovic; Gregory Hale; Timothy A Driscoll; Paul L Martin; Kristin M Page; Ketti Flickinger; Jerelyn Moffet; Donna Niedzwiecki; Joanne Kurtzberg; Paul Szabolcs
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.